Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies.
Henley DB, Sundell KL, Sethuraman G, Siemers ER; Alzheimer’s Disease Neuroimaging Initiative.
Alzheimers Dement. 2011 Dec 2. [Epub ahead of print]
Related citations
Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.
Glass DJ, Arnold SE.
Alzheimers Dement. 2011 Nov 30. [Epub ahead of print]
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ.
Am J Pathol. 2012 Feb;180(2):526-40. Epub 2011 Dec 3.
Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture.
Marcantonio ER, Palihnich K, Appleton P, Davis RB.
J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S282-8. doi: 10.1111/j.1532-5415.2011.03691.x.
Plasma homocysteine level and apathy in Alzheimer's disease.
Chen CS, Yeh YC, Chang YS, Huang MF.
J Am Geriatr Soc. 2011 Sep;59(9):1752-4. doi: 10.1111/j.1532-5415.2011.03550.x. No abstract available.
Error occurred: cannot get document summary
Alzheimer disease: Amyloid-targeting antibody performs well in phase II trial.
Kingwell K.
Nat Rev Neurol. 2011 Dec 7;7(12):657. doi: 10.1038/nrneurol.2011.183. No abstract available.
Alzheimer disease: AD pathology--emerging subtypes or age-of-onset spectrum?
Masliah E, Hansen LA.
Nat Rev Neurol. 2011 Dec 6;8(1):11-2. doi: 10.1038/nrneurol.2011.205. No abstract available.
CSF biomarkers for Alzheimer's disease: current utility and potential future use.
Holtzman DM.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S4-9.
Potential of functional MRI as a biomarker in early Alzheimer's disease.
Sperling R.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S37-43. Review.
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.
Klunk WE.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S20-36. Review.
Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.
Mayeux R, Schupf N.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S10-9. Review.
Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
Morris JC, Selkoe DJ.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S1-3. No abstract available.
Cell biology. Yeast informs Alzheimer's disease.
McGurk L, Bonini NM.
Science. 2011 Dec 2;334(6060):1212-3. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on